Centralization and Specialization of R&D and Quality Control Functions
First written in FY2017. 21 of 29 entries say "Restated". Latest entry: FY2026.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥954 million, primarily related to its livestock and aquatic feed businesses.」
R&D expenses increased from ¥917 million in the previous fiscal year to ¥954 million. Research results including new products for poultry, swine, and cattle feed, insect protein, and compensatory growth technologies are being developed into products and technologies. - 2026-05-27AdvancedGeneral Meetings of Shareholders
「We will introduce the latest equipment, including milking and nursing robots, an automated feeding system, and Japan’s first multi-animal methane measurement system, to reduce environmental impact while strengthening product development capabilities. (Scheduled to begin operation in July 2027.)」
The company has specified plans to integrate the Iwaki Research Center into the Fukushima Research Center, construct a cattle research facility costing approximately ¥1.0 billion, and install methane-measurement and other equipment, including the planned operating date. - FY2026-H1RestatedAnnual report
「The Group's R&D expenses for the cumulative interim period were ¥493 million. There were no material changes in the status of the Group's research and development activities during the cumulative interim period.」
While stating that there had been no material changes in research and development activities, the Group disclosed interim R&D expenses of ¥493 million. - FY2025AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥917 million, primarily related to its livestock and aquatic feed businesses.」
R&D expenses increased from ¥853 million in the previous fiscal year to ¥917 million. Research results including methane reduction, low-protein feed, eliminating fishmeal and fish oil, and IoT are being developed into products and technologies. - FY2025-H1RestatedAnnual report
「The Group's R&D expenses for the cumulative interim period were ¥452 million. There were no material changes in the status of the Group's research and development activities during the cumulative interim period.」
The Group stated that there had been no material changes in research and development activities and disclosed interim R&D expenses of ¥452 million. - FY2024AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥853 million, primarily related to its feed business.」
The Group continued its R&D structure, and R&D expenses increased from ¥790 million in the previous fiscal year to ¥853 million. Research themes including low-fishmeal and fishmeal-free feed, reducing environmental impact, and IoT have also progressed. - FY2024-Q3RestatedAnnual report
「The Group's R&D expenses for the cumulative third quarter were ¥634 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
Having reconfirmed that there have been no material changes in research and development activities, cumulative R&D expenses of ¥634 million for the third quarter have been disclosed. - FY2024-Q2RestatedAnnual report
「The Group's R&D expenses for the cumulative second quarter were ¥413 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the second quarter are reported as ¥413 million. - FY2024-Q1RestatedAnnual report
「The Group's R&D expenses for the cumulative first quarter were ¥195 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
Having reconfirmed that there have been no material changes in research and development activities, cumulative R&D expenses of ¥195 million for the first quarter have been disclosed. - FY2023AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥790 million, primarily related to its feed business. In FY2022, it launched the Mamacoro Series of milk replacer products.」
R&D expenses increased from ¥755 million in the previous fiscal year to ¥790 million, and the Mamacoro Series, incorporating new materials and an intestinal health concept for swine feed, was newly launched. - FY2023-Q3RestatedAnnual report
「The Group's R&D expenses for the cumulative third quarter were ¥589 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the third quarter are reported as ¥589 million. - FY2023-Q2RestatedAnnual report
「The Group's R&D expenses for the cumulative second quarter were ¥391 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The Group stated that there had been no material changes in research and development activities and reported cumulative R&D expenses of ¥391 million for the second quarter. - FY2023-Q1RestatedAnnual report
「The Group's R&D expenses for the cumulative first quarter were ¥190 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the first quarter are reported as ¥190 million. - FY2022AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥755 million, primarily related to its feed business.」
The Group continued to consolidate and specialize its R&D structure and recorded R&D expenses of ¥755 million for FY2022. Research themes including reducing environmental impact, IoT, and reducing the use of fishmeal and fish oil have also been developed into specific initiatives. - FY2022-Q3RestatedAnnual report
「The Group's R&D expenses for the cumulative third quarter were ¥577 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the third quarter are reported as ¥577 million. - FY2022-Q2RestatedAnnual report
「The Group's R&D expenses for the cumulative second quarter were ¥388 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the second quarter are reported as ¥388 million. - FY2022-Q1RestatedAnnual report
「The Group's R&D expenses for the cumulative first quarter were ¥190 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the first quarter are reported as ¥190 million. - FY2021-Q3RestatedAnnual report
「The Group's R&D expenses for the cumulative third quarter were ¥566 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
Having reconfirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the third quarter are reported as ¥566 million. - FY2021-Q2RestatedAnnual report
「The Group's R&D expenses for the cumulative second quarter were ¥380 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
Having confirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the second quarter are reported as ¥380 million. - FY2021-Q1RestatedAnnual report
「The Group's R&D expenses for the cumulative first quarter were ¥191 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
Having confirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the first quarter are reported as ¥191 million. - FY2020-Q3RestatedAnnual report
「The Group's R&D expenses for the cumulative third quarter were ¥551 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
Having confirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the third quarter are reported as ¥551 million. - FY2020-Q2RestatedAnnual report
「The Group's R&D expenses for the cumulative second quarter were ¥378 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
Having confirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the second quarter are reported as ¥378 million. - FY2020-Q1RestatedAnnual report
「The group’s research and development expenses for the consolidated cumulative first quarter were ¥188 million. There were no material changes in the status of the group’s research and development activities during the consolidated cumulative first quarter.」
Having confirmed that there have been no material changes in research and development activities, the cumulative R&D expenses for the first quarter are reported as ¥188 million. - FY2019-Q1RestatedAnnual report
「The group’s research and development expenses for the consolidated cumulative first quarter were ¥184 million. There were no material changes in the status of the group’s research and development activities during the consolidated cumulative first quarter.」
The company confirmed that there were no material changes in its research and development activities and reported research and development expenses of ¥184 million for the cumulative first quarter. - FY2018AdvancedAnnual report
「In April 2018, the Development and Biosecurity Office was reorganized. Biosecurity operations were transferred to the Head Office’s Livestock Feed Division, while research related to laboratory animal feed, bee feed and pet food was reorganized as the Small Animal Section newly established within the Livestock Research Laboratory.」
Regarding research and development and biosecurity functions, biosecurity operations were transferred to the Head Office in April 2018, and small-animal-related research was reorganized into a newly established section within the Livestock Research Laboratory. - FY2018-Q3RestatedAnnual report
「The group’s research and development expenses for the consolidated cumulative third quarter were ¥603 million. There were no material changes in the status of the group’s research and development activities during the consolidated cumulative third quarter.」
The company confirmed that there were no material changes in its research and development activities and reported research and development expenses of ¥603 million for the cumulative third quarter. - FY2018-Q2RestatedAnnual report
「The group’s research and development expenses for the consolidated cumulative second quarter were ¥398 million. There were no material changes in the status of the group’s research and development activities during the consolidated cumulative second quarter.」
The company confirmed that there were no material changes in its research and development activities and reported research and development expenses of ¥398 million for the cumulative second quarter. - FY2018-Q1RestatedAnnual report
「The group’s research and development expenses for the consolidated cumulative first quarter were ¥206 million. There were no material changes in the status of the group’s research and development activities during the consolidated cumulative first quarter.」
The company confirmed that there were no material changes in its research and development activities and reported research and development expenses of ¥206 million for the cumulative first quarter. - FY2017First statedAnnual report
「Research and development activities are conducted at the “Research Institute,” which develops and controls the quality of livestock and laboratory animal feed and provides biosecurity services, and at the “Aquaculture Research Laboratory,” which conducts research and development on aquaculture feed and feed properties. At the Research Institute, research facilities and personnel for testing and product development have been consolidated, and the latest information from Japan and overseas is incorporated to advance more efficient, faster and higher-quality research and development at well-equipped facilities. Research and development expenses for the consolidated fiscal year were ¥751 million, mainly in the feed business.」
Research and development functions have been consolidated at the Research Institute and Aquaculture Research Laboratory, with a research structure covering quality control and biosecurity services. Research and development expenses were ¥751 million for the consolidated fiscal year.